PROM1 and neoplasm: As reported by Yang et al., upregulation of miR-29a in CD133+ glioblastoma cells increased cisplatin-induced apoptosis and decreased survival of CD133+ tumor-bearing mice after treatment with cisplatin [142] (Figure 3).